PHAT Financials
Phathom Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$0.00
Market Cap
$622.74M
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$55.25M
Gross Profit
-
Operating Income
-
Net Income
$-334.33M
EPS (Diluted)
$-5.29
Balance Sheet Highlights
Total Assets
$378.32M
Total Liabilities
$631.90M
Shareholders Equity
-
Cash & Equivalents
$297.26M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-266.77M
CapEx
-
Free Cash Flow
-
Profitability Metrics
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is PHAT revenue?
PHAT's most recent quarterly revenue was $55.25M. Annual revenue can be calculated by summing the four most recent quarters.
Is PHAT profitable?
PHAT reported a loss of $334.33M in the most recent quarter.
What is PHAT market cap?
PHAT has a market capitalization of $622.74M, making it a small-cap stock.
Does PHAT have debt?
View PHAT's balance sheet for debt information.
What is PHAT cash flow?
Cash flow data is available in the full financial statements.